Theravance Biopharma Inc (TBPH)
9.46
+0.09
(+0.96%)
USD |
NASDAQ |
May 03, 16:00
9.46
0.00 (0.00%)
After-Hours: 20:00
Theravance Biopharma Price: 9.46 for May 3, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 03, 2024 | 9.48 | 9.625 | 9.29 | 9.46 | 330843.0 |
| May 02, 2024 | 8.90 | 9.375 | 8.875 | 9.37 | 455299.0 |
| May 01, 2024 | 8.44 | 8.98 | 8.40 | 8.84 | 2.057M |
| Apr 30, 2024 | 8.98 | 8.98 | 8.42 | 8.44 | 368631.0 |
| Apr 29, 2024 | 9.14 | 9.22 | 8.95 | 8.99 | 293236.0 |
| Apr 26, 2024 | 9.13 | 9.27 | 9.06 | 9.12 | 263498.0 |
| Apr 25, 2024 | 9.14 | 9.33 | 9.00 | 9.14 | 387247.0 |
| Apr 24, 2024 | 9.14 | 9.26 | 9.05 | 9.17 | 297149.0 |
| Apr 23, 2024 | 9.45 | 9.61 | 9.19 | 9.22 | 335578.0 |
| Apr 22, 2024 | 9.32 | 9.47 | 9.25 | 9.46 | 309740.0 |
| Apr 19, 2024 | 9.13 | 9.38 | 9.02 | 9.34 | 433019.0 |
| Apr 18, 2024 | 9.51 | 9.52 | 9.15 | 9.20 | 362260.0 |
| Apr 17, 2024 | 9.68 | 9.85 | 9.49 | 9.52 | 307877.0 |
| Apr 16, 2024 | 9.88 | 9.88 | 9.585 | 9.69 | 472501.0 |
| Apr 15, 2024 | 9.53 | 9.98 | 9.488 | 9.92 | 517519.0 |
| Apr 12, 2024 | 9.55 | 10.44 | 9.45 | 9.61 | 783427.0 |
| Apr 11, 2024 | 9.50 | 9.61 | 8.825 | 8.93 | 472613.0 |
| Apr 10, 2024 | 9.35 | 9.55 | 9.18 | 9.54 | 468773.0 |
| Apr 09, 2024 | 9.48 | 9.63 | 9.30 | 9.48 | 507606.0 |
| Apr 08, 2024 | 9.29 | 9.51 | 9.21 | 9.47 | 371772.0 |
| Apr 05, 2024 | 9.14 | 9.33 | 9.05 | 9.31 | 346351.0 |
| Apr 04, 2024 | 9.37 | 9.42 | 9.05 | 9.14 | 438871.0 |
| Apr 03, 2024 | 9.07 | 9.32 | 9.00 | 9.29 | 476529.0 |
| Apr 02, 2024 | 8.93 | 9.12 | 8.79 | 9.10 | 458264.0 |
| Apr 01, 2024 | 8.99 | 9.04 | 8.75 | 9.03 | 317724.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
6.77
Minimum
Sep 15 2021
31.21
Maximum
Feb 05 2020
14.46
Average
11.20
Median
Jan 06 2023
Price Benchmarks
| Corcept Therapeutics Inc | 24.52 |
| Nektar Therapeutics | 1.57 |
| Vanda Pharmaceuticals Inc | 4.88 |
| Fate Therapeutics Inc | 4.06 |
| FibroGen Inc | 1.14 |
Price Related Metrics
| PS Ratio | 9.115 |
| Price to Book Value | 2.139 |
| Earnings Yield | -10.25% |
| Market Cap | 455.64M |